FDA Warning Letter — Intas Pharmaceuticals Ltd.
The FDA took a Warning Letter action against Intas Pharmaceuticals Ltd. on Mar 30, 2026 (Selaqui, India). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Intas Pharmaceuticals Ltd.
- Date
- Mar 30, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Center
- CDER
- Location
- Selaqui (India)